Nuclear Medicine & Radiopharmaceuticals Market, Global Outlook and Forecast 2023-2029

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imagedﾗfor example, positronemitting radiopharmaceuticals.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine & Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine & Radiopharmaceuticals. This report contains market size and forecasts of Nuclear Medicine & Radiopharmaceuticals in global, including the following market information:
Global Nuclear Medicine & Radiopharmaceuticals Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Nuclear Medicine & Radiopharmaceuticals Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Nuclear Medicine & Radiopharmaceuticals companies in 2022 (%)
The global Nuclear Medicine & Radiopharmaceuticals market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nuclear Medicine & Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Medicine & Radiopharmaceuticals Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, by Type, 2022 (%)
    Diagnostic
    Therapeutic
Global Nuclear Medicine & Radiopharmaceuticals Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, by Application, 2022 (%)
    Oncology
    Thyroid
    Cardiology
    Others
Global Nuclear Medicine & Radiopharmaceuticals Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nuclear Medicine & Radiopharmaceuticals revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Nuclear Medicine & Radiopharmaceuticals revenues share in global market, 2022 (%)
Key companies Nuclear Medicine & Radiopharmaceuticals sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Nuclear Medicine & Radiopharmaceuticals sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    China Isotope & Radiation
    Dongcheng
    Jaco
    Ciaeriar
    Advanced Molecular-imaging Solution
    Shanghai Atom Kexing
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nuclear Medicine & Radiopharmaceuticals, market overview.
Chapter 2: Global Nuclear Medicine & Radiopharmaceuticals market size in revenue and volume.
Chapter 3: Detailed analysis of Nuclear Medicine & Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nuclear Medicine & Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Nuclear Medicine & Radiopharmaceuticals capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.